38%
Percent of respondents who said one or more medication errors are related to a drug shortage
$359M
Cost of labor needed to manage drug shortages per year
8.6M
Additional hours of labor per year to manage drug shortages
Advanced analytics
Manage stock and lessen the impact of drug shortages on patient care with insights we provide from our advanced analytics
Collaborative partnerships
Develop sustainable drug shortage solutions collaboratively with pharmaceutical manufacturers, wholesalers and regulatory bodies
Alternative sourcing strategies
Identify alternative sources for critical medications, providing continuity of care even during shortages with our insights and support
Consistent access to medications
Provide uninterrupted patient care
Essential medications for high-quality patient care
As part of the mission to end drug shortages, Vizient pharmacy experts identify essential medications where, if not available, would prove the greatest threat to a hospital’s ability to provide immediate and high-quality patient care.
Key performance indicators for the management of drug shortages
Drug shortages impact the ability to provide critical patient care and require a large amount of time and expertise to manage. Through the implementation of drug shortage KPIs, the financial, operational, clinical and workforce aspects of drug shortages and the gaps in current practices can be better understood.
Developed by a Vizient workgroup comprising 49 drug shortage experts from various hospitals and health systems, this report outlines KPIs to measure the effectiveness of drug shortage management strategies at the organizational level.
Novaplus
Novaplus, the Vizient private-label, offers financial value, quality and support on pharmaceuticals, medical-surgical products and purchased services offerings.
The program supports a more resilient pharmaceutical supply chain by offering additional transparency and inventory. Many of the nation’s leading healthcare systems rely on Novaplus for consistent access, market-competitive pricing and ongoing value. More than 50% of essential medications are accessible through the Novaplus program.
Novaplus delivers cost savings that are competitive compared to other options in the market. It’s also very convenient for our staff and allows us to focus our activities on other higher priority issues.
Eric Tichy, PharmD, MBA
Vice Chair, Pharmacy Supply Solutions, Mayo Clinic
The Novaplus Enhanced Supply (NES) program improves supply chain resiliency and helps end product shortages via transparency, accountability and commitment to supply
Suppliers of the NES program produce additional inventory of both the Novaplus label and manufacturer label product based on total historical purchases by Vizient pharmacy program participants. With more than 3,100 hospitals and 95% of academic medical centers, this drives more inventory and flexibility for both contracted and 340B-eligible purchases.
Novaplus Enhanced Supply (NES) Reserve
Tailored specifically to meet the needs of providers who seek additional supply assurance and additional value, this program is an extension of our Novaplus and NES programs. Through NES Reserve, participants gain access to six months of dedicated inventory solely for their access. This inventory is warehoused in the U.S. by Vizient supplier partners, ensuring access to the most critical inventory at the right time.
Why partner with Vizient
- Proven history: With years of experience in healthcare supply chain management, Vizient has a proven track record of delivering effective solutions to address drug shortages.
- Comprehensive solutions: From a suite of analytics to dedicated inventory, Vizient offers solutions to help healthcare providers.
- Commitment to excellence: We are committed to excellence in healthcare, continuously innovating to meet the evolving needs of our providers and the patients they serve.